logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Diabetic Retinopathy Current Pharmacologic Treatment And Emerging Strategies 1st Edition Michael W Stewart Auth

  • SKU: BELL-5886792
Diabetic Retinopathy Current Pharmacologic Treatment And Emerging Strategies 1st Edition Michael W Stewart Auth
$ 31.00 $ 45.00 (-31%)

4.8

104 reviews

Diabetic Retinopathy Current Pharmacologic Treatment And Emerging Strategies 1st Edition Michael W Stewart Auth instant download after payment.

Publisher: ADIS
File Extension: PDF
File size: 6.76 MB
Pages: 278
Author: Michael W. Stewart (auth.)
ISBN: 9789811035081, 9789811035098, 9811035083, 9811035091
Language: English
Year: 2017
Edition: 1

Product desciption

Diabetic Retinopathy Current Pharmacologic Treatment And Emerging Strategies 1st Edition Michael W Stewart Auth by Michael W. Stewart (auth.) 9789811035081, 9789811035098, 9811035083, 9811035091 instant download after payment.

A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets.

Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option.

Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.

Related Products

Diabetic Retinopathy M Ola

4.3

8 reviews
$45.00 $31.00

Diabetic Retinopathy P Kroll

4.0

36 reviews
$45.00 $31.00